Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
Acorda Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2023
Acorda Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2023.
In 2021, five executives at Acorda Therapeutics received on average a compensation package of $972K, a 9% increase compared to previous year.
Average pay of disclosed executives at Acorda Therapeutics
Ron Cohen, Chief Executive Officer, received $1.6M in total, which increased by 9% compared to 2020. 45% of Cohen's compensation, or $743K, was in salary. Cohen also received $459K in non-equity incentive plan, $253K in option awards, $182K in stock awards, as well as $8.7K in other compensation.
For fiscal year 2021, the median employee pay was $226,642 at Acorda Therapeutics. Therefore, the ratio of Ron Cohen's pay to the median employee pay was 7 to one.
Burkhard Blank, Chief Medical Officer, received a compensation package of $1.4M, which increased by 67% compared to previous year. 38% of the compensation package, or $542K, was in other compensation.
Lauren Sabella, Chief Operating Officer, earned $811K in 2021, a 7% increase compared to previous year.
Kerry Clem, Chief Commercial Officer, received $662K in 2021, which increases by 10% compared to 2020.
Michael Gesser, Chief Finance Officer and Treasurer, earned $305K in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2023.